Mathematical Modelling of Alternative Pathway of Complement System

被引:0
|
作者
Suruchi Bakshi
Fraser Cunningham
Eva-Maria Nichols
Marta Biedzka-Sarek
Jessica Neisen
Sebastien Petit-Frere
Christina Bessant
Loveleena Bansal
Lambertus A. Peletier
Stefano Zamuner
Piet H. van der Graaf
机构
[1] Leiden University,Division of Systems Biomedicine and Pharmacology, LACDR
[2] Certara QSP,Cytokine, Chemokine and Complement DPU, Immunoinflammation TA Unit
[3] GSK,Computational and Modelling Sciences, Platform Technology Sciences
[4] GSK,Mathematical Institute
[5] Leiden University,Clinical Pharmacology, Modelling and Simulation
[6] GSK,undefined
[7] Certara QSP,undefined
来源
Bulletin of Mathematical Biology | 2020年 / 82卷
关键词
Alternative pathway; Complement system; Immunology; C3 glomerulopathy;
D O I
暂无
中图分类号
学科分类号
摘要
The complement system (CS) is an integral part of innate immunity and can be activated via three different pathways. The alternative pathway (AP) has a central role in the function of the CS. The AP of complement system is implicated in several human disease pathologies. In the absence of triggers, the AP exists in a time-invariant resting state (physiological steady state). It is capable of rapid, potent and transient activation response upon challenge with a trigger. Previous models of AP have focused on the activation response. In order to understand the molecular machinery necessary for AP activation and regulation of a physiological steady state, we built parsimonious AP models using experimentally supported kinetic parameters. The models further allowed us to test quantitative roles played by negative and positive regulators of the pathway in order to test hypotheses regarding their mechanisms of action, thus providing more insight into the complex regulation of AP.
引用
收藏
相关论文
共 50 条
  • [41] ACTIVITY OF MURINE COMPLEMENT ALTERNATIVE PATHWAY
    LUKIC, G
    MILETIC, VD
    RADOJICIC, C
    DUJIC, A
    PERIODICUM BIOLOGORUM, 1983, 85 : 159 - 161
  • [42] The alternative pathway of complement and the thrombotic microangiopathies
    Teoh, Chia Wei
    Riedl, Magdalena
    Licht, Christoph
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (02) : 220 - 231
  • [43] NOMENCLATURE OF THE ALTERNATIVE ACTIVATING PATHWAY OF COMPLEMENT
    AUSTEN, KF
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1982, 47 (01): : 221 - 224
  • [44] CHARACTERIZATION OF THE ALTERNATIVE COMPLEMENT PATHWAY OF CARP
    MATSUYAMA, H
    TANAKA, K
    NAKAO, M
    YANO, T
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1988, 12 (02): : 403 - 408
  • [45] ABNORMALITIES IN THE ALTERNATIVE PATHWAY OF COMPLEMENT IN PSORIASIS
    MARLEY, WM
    BELEW, PW
    ROSENBERG, EW
    URMSON, JR
    STITZEL, AE
    SPITZER, RE
    CLINICAL RESEARCH, 1981, 29 (04): : A798 - A798
  • [46] ABNORMALITIES IN THE ALTERNATIVE PATHWAY OF COMPLEMENT IN PSORIASIS
    MARLEY, WM
    BELEW, PW
    ROSENBERG, EW
    URMSON, JR
    STITZEL, AE
    SPITZER, RE
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1982, 7 (04) : 387 - 395
  • [47] REGULATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY PH
    FISHELSON, Z
    HORSTMANN, RD
    MULLEREBERHARD, HJ
    JOURNAL OF IMMUNOLOGY, 1987, 138 (10): : 3392 - 3395
  • [48] Looking back on the alternative complement pathway
    Lachmann, Peter J.
    IMMUNOBIOLOGY, 2018, 223 (8-9) : 519 - 523
  • [50] CLASSICAL AND ALTERNATIVE PATHWAY OF COMPLEMENT IN AMPHIBIA
    DLABAC, V
    SIMECKOVA, J
    SIMA, P
    HOFMANOVA, B
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1983, 7 (04): : 783 - 784